There are 2 papers on aging in Preclinical models: none in people yet, 2 in animals.
2 papers study it4 findings
See all 2 papers on Preclinical models
- Animals2
Interventions
3Urolithin A
downmitochondrial dysfunction1upsystolic and diastolic heart function1
1 study
Urolithin A
downmitochondrial dysfunction1upsystolic and diastolic heart function1
Urolithin A decreases mitochondrial dysfunction in preclinical models of aging and heart failure.
“UA oral administration successfully counteracts mitochondrial and cardiac dysfunctions in preclinical models of aging and heart failure.”
Animalsin preclinical models of aging and heart failure
bioRxiv (Cold Spring Harbor Laboratory)Preprint
Urolithin A improves systolic and diastolic heart function in preclinical models of aging and heart failure.
“UA improves both systolic and diastolic heart functions, distinguishing it from other mitochondrial interventions.”
Animalsin preclinical models of aging and heart failureheart
bioRxiv (Cold Spring Harbor Laboratory)Preprint
Amino acid supplement
upgene editing efficiency1
1 study
Amino acid supplement
upgene editing efficiency1
Amino acid supplement increases gene editing efficiency in P. models (intratracheal route).
“Delivery of gene editing materials by LNP and AAS through an intratracheal route increased lung-targeted in vivo gene editing efficiency compared with LNP alone.”
Animalsintratracheal routelung
Science translational medicine
Lac-phe
downbody weight1
1 study
Lac-phe
downbody weight1
Lac-phe decreases body weight in obesity.
“Its administration suppresses appetite and reduces body weight in obesity”
Reviewin obesity
The Journal of pharmacology and experimental therapeutics